Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | NovoCure Ltd | Leonard Frank X
(EVP, Pres., Novocure Oncology) |
S | Ordinary Shares | D | 2519 | $16.01 - $16.03 | $40,357 |
| 2024-02-27 | NovoCure Ltd | Cordova Ashley
(Chief Financial Officer) |
A | Ordinary Shares | A | 102249 | $16.30 - $16.30 | $1,666,658 |
| 2024-02-27 | NovoCure Ltd | Weinberg Uri
(Chief Innovation Officer) |
A | Ordinary Shares | A | 81799 | $16.30 - $16.30 | $1,333,323 |
| 2024-02-27 | NovoCure Ltd | Giladi Moshe
(Chief Science Officer) |
A | Ordinary Shares | A | 51124 | $16.30 - $16.30 | $833,321 |
| 2023-10-31 | NovoCure Ltd | Puri Michal Nath
(Chief Human Resources Officer) |
A | Ordinary Shares | A | 37593 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |